このエントリーをはてなブックマークに追加
ID 54608
JaLCDOI
フルテキストURL
70_5_429.pdf 2.05 MB
著者
Asano, Takeru Department of Hematology and Oncology, Okayama University Hospital
Matsuoka, Ken-ichi Department of Hematology and Oncology, Okayama University Hospital ORCID Kaken ID
Iyama, Satoshi Department of Medical Oncology and Hematology, Sapporo Medical University Hospital
Ohashi, Kazuteru Hematology division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
Inamoto, Yoshihiro Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
Ohwada, Chikako Department of Hematology, Chiba University Hospital
Murata, Makoto Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
Satake, Atsushi First Department of Internal Medicine, Kansai Medical University
Yoshida, Chikamasa Division of Hematology, National Hospital Organization Minami-Okayama Medical Center
Nakase, Koichi Division of Hematology, Ehime Prefectural Central Hospital
Mori, Yasuo Department of Hematology and Oncology, Kyushu University Hospital
Tanimoto, Mitsune Department of Hematology and Oncology, Okayama University Hospital Kaken ID publons researchmap
抄録
Chronic graft versus host disease (cGVHD) remains a major problem for long survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Currently, corticosteroid therapy is effective for cGVHD as the first line therapy. However, prolonged therapy with corticosteroids causes various severe adverse events. To develop the new therapeutic strategy of cGVHD, we have launched a multicenter phase I/IIa clinical trial of low dose subcutaneous interleukin-2 (IL-2) for treatment of steroid refractory cGVHD, which is constituted of 2 sequential phases (induction phase and maitanance phase). This study will provide the new therapeutic option for patients with refractory cGVHD after allogeneic HSCT.
キーワード
chronic GVHD
allogeneic HSCT
steroid refractory
IL-2
Amo Type
Clinical Study Protocols
出版物タイトル
Acta Medica Okayama
発行日
2016-10
70巻
5号
出版者
Okayama University Medical School
開始ページ
429
終了ページ
433
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
英語
著作権者
CopyrightⒸ 2016 by Okayama University Medical School
論文のバージョン
publisher
査読
有り
PubMed ID
Web of Science KeyUT